🇺🇸 FDA
Pipeline program

IMJUDO 20 mg/ml concentrate for solution for infusion., IMFINZI 50 mg/mL concentrate for solution for infusion.

IMMUWHY

Phase 2 small_molecule active

Quick answer

IMJUDO 20 mg/ml concentrate for solution for infusion., IMFINZI 50 mg/mL concentrate for solution for infusion. for Advanced stage intrahepatic biliary tract cancer (BTC) is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
Advanced stage intrahepatic biliary tract cancer (BTC)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials